Dr. Rachel Lena Miller, MD

Dr. Miller practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Miller's NPI, 1235297243, was assigned on December 4, 2006. Dr. Miller graduated from New York University School of Medicine in 1990. Dr. Miller holds New York license 187277.

Dr. Miller's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121. Dr. Miller also practices at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.

Dr. Miller's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Miller is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Miller to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Miller's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Miller is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Miller is licensed in New York.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Miller treats.

CMS data shows 258 Medicare services from Dr. Miller across 5 procedure codes in 2024, for 89 Medicare patients. Medicare paid $17,635 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Dr. Miller in 2024. The largest group is 65 to 74, with 45 patients. 72% of them have high cholesterol, and 57% have arthritis. 16% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Miller's median patient age at 40, with 65% women.

In 2024, Dr. Miller wrote 378 Medicare Part D claims for 56 patients. 75% of them were for generic drugs. CMS names the drug for 278 of them, across 9 drugs with 11 or more claims each, at $17,295 in total drug cost. In 2023, CMS named 278 claims across 9 drugs.

Dr. Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miller as offering telehealth.

Dmand AI links 171 papers to Dr. Miller, published from 2006 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Asthma, Environmental Exposure and New York City. Dr. Miller has published most often in J Allergy Clin Immunol. Dr. Miller's most frequent co-authors are Stephanie Lovinsky-Desir, MD, Diane R. Gold, MD and Daniel J. Jackson, MD.

Dmand AI links Dr. Miller to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Primary Immunodeficiency Diseases and Asthma.

CMS Open Payments shows 3 general payments to Dr. Miller from 2 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $45.

Dmand AI lists 11 awards for Dr. Miller, most recently Sheldon L. Spector, MD FAAAAI Memorial Lectureship at the AAAAI/ACAAI Joint Congress for delivering the talk “Epigenetic Changes Ascribed to Pollutant Exposures” in 2018.

Dr. Miller graduated from New York University School of Medicine in 1990. Dr. Miller is a member of AAAAI.

Dr. Miller is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.